Ciska Verbaanderd

778 total citations
12 papers, 526 citations indexed

About

Ciska Verbaanderd is a scholar working on Economics and Econometrics, Physiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ciska Verbaanderd has authored 12 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Economics and Econometrics, 5 papers in Physiology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ciska Verbaanderd's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Biomedical Ethics and Regulation (5 papers) and Pharmaceutical Economics and Policy (5 papers). Ciska Verbaanderd is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Biomedical Ethics and Regulation (5 papers) and Pharmaceutical Economics and Policy (5 papers). Ciska Verbaanderd collaborates with scholars based in Belgium, United Kingdom and United States. Ciska Verbaanderd's co-authors include Pan Pantziarka, Lydie Meheus, Isabelle Huys, Gauthier Bouche, Vikas P. Sukhatme, Vidula Sukhatme, Ilse Rooman, Marco B.E. Schaaf, Hannelore Maes and Patrizia Agostinis and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Seminars in Cancer Biology and Frontiers in Pharmacology.

In The Last Decade

Ciska Verbaanderd

12 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ciska Verbaanderd Belgium 9 216 100 100 75 69 12 526
Shwu‐Luan Lee United States 6 353 1.6× 118 1.2× 34 0.3× 24 0.3× 54 0.8× 7 655
Steven V. Molinski Canada 14 334 1.5× 182 1.8× 51 0.5× 66 0.9× 27 0.4× 19 874
Sally Clive United Kingdom 13 178 0.8× 190 1.9× 28 0.3× 13 0.2× 62 0.9× 30 500
Alison Acevedo United States 5 166 0.8× 112 1.1× 18 0.2× 23 0.3× 87 1.3× 8 428
Monika Lamba Saini India 12 269 1.2× 261 2.6× 24 0.2× 25 0.3× 69 1.0× 32 668
Kristen M. John United States 3 329 1.5× 136 1.4× 44 0.4× 73 1.0× 39 0.6× 5 745
Yu He China 11 150 0.7× 169 1.7× 54 0.5× 12 0.2× 43 0.6× 41 438
Cynthia M. Nijenhuis Netherlands 14 172 0.8× 202 2.0× 29 0.3× 20 0.3× 26 0.4× 28 535
Shufen Cao United States 13 218 1.0× 116 1.2× 35 0.3× 9 0.1× 52 0.8× 43 503
Yao Xie China 13 308 1.4× 276 2.8× 121 1.2× 26 0.3× 124 1.8× 43 822

Countries citing papers authored by Ciska Verbaanderd

Since Specialization
Citations

This map shows the geographic impact of Ciska Verbaanderd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ciska Verbaanderd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ciska Verbaanderd more than expected).

Fields of papers citing papers by Ciska Verbaanderd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ciska Verbaanderd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ciska Verbaanderd. The network helps show where Ciska Verbaanderd may publish in the future.

Co-authorship network of co-authors of Ciska Verbaanderd

This figure shows the co-authorship network connecting the top 25 collaborators of Ciska Verbaanderd. A scholar is included among the top collaborators of Ciska Verbaanderd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ciska Verbaanderd. Ciska Verbaanderd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Verbaanderd, Ciska, et al.. (2023). Biomarker‐Driven Developments in the Context of the New Regulatory Framework for Companion Diagnostics in the European Union. Clinical Pharmacology & Therapeutics. 114(2). 316–324. 6 indexed citations
2.
Simoens, Steven, Liese Barbier, Rosanne Janssens, et al.. (2022). How to balance valuable innovation with affordable access to medicines in Belgium?. Frontiers in Pharmacology. 13. 960701–960701. 7 indexed citations
3.
Zarkavelis, George, Ciska Verbaanderd, Nathan I. Cherny, et al.. (2022). Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines. ESMO Open. 8(1). 100604–100604. 9 indexed citations
4.
Verbaanderd, Ciska, Ilse Rooman, & Isabelle Huys. (2021). Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research. Trials. 22(1). 322–322. 20 indexed citations
5.
Verjans, Robin, Ciska Verbaanderd, Hubert G. M. Leufkens, et al.. (2021). Extension of Indication for Authorised Oncology Products in the European Union: A Joint Effort of Multiple Stakeholders. Frontiers in Medicine. 8. 790782–790782. 3 indexed citations
6.
Verbaanderd, Ciska, Ilse Rooman, Lydie Meheus, & Isabelle Huys. (2020). On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients. Frontiers in Pharmacology. 10. 1664–1664. 48 indexed citations
7.
Verbaanderd, Ciska, et al.. (2020). Sharing of Clinical Trial Data and Samples: The Cancer Patient Perspective. Frontiers in Medicine. 7. 33–33. 8 indexed citations
8.
Pantziarka, Pan, Ciska Verbaanderd, Isabelle Huys, Gauthier Bouche, & Lydie Meheus. (2020). Repurposing drugs in oncology: From candidate selection to clinical adoption. Seminars in Cancer Biology. 68. 186–191. 41 indexed citations
9.
Pantziarka, Pan, Ciska Verbaanderd, Vidula Sukhatme, et al.. (2018). ReDO_DB: the repurposing drugs in oncology database. ecancermedicalscience. 12. 886–886. 99 indexed citations
10.
Verbaanderd, Ciska, Hannelore Maes, Marco B.E. Schaaf, et al.. (2017). Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents. ecancermedicalscience. 11. 781–781. 203 indexed citations
11.
Verbaanderd, Ciska, Lydie Meheus, Isabelle Huys, & Pan Pantziarka. (2017). Repurposing Drugs in Oncology: Next Steps. Trends in cancer. 3(8). 543–546. 61 indexed citations
12.
Agbaje, Jimoh Olubanwo, et al.. (2015). Neuropathy of Trigeminal Nerve Branches After Oral and Maxillofacial Treatment. Journal of Maxillofacial and Oral Surgery. 15(3). 321–327. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shwu‐Luan Lee Breakdown of academic impact, for papers by Steven V. Molinski Breakdown of academic impact, for papers by Sally Clive Breakdown of academic impact, for papers by Alison Acevedo Breakdown of academic impact, for papers by Monika Lamba Saini Breakdown of academic impact, for papers by Kristen M. John Breakdown of academic impact, for papers by Yu He Breakdown of academic impact, for papers by Cynthia M. Nijenhuis Breakdown of academic impact, for papers by Shufen Cao Breakdown of academic impact, for papers by Yao Xie
Rankless by CCL
2026